Immunotherapy using T cell defined tumor antigens for melanoma

Microbiology and Immunology

Volumn 42, Issue 12, 1998, Pages 803-813

  Kawakami, Yutaka ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dendritic cells; Immunotherapy; Melanosomal proteins; Peptides; Tumor antigens

Indexed keywords

EPITOPE; MELANOMA ANTIGEN; SYNTHETIC PEPTIDE; TUMOR ANTIGEN; TUMOR PROTEIN;

ADOPTIVE TRANSFER; ANTIGEN RECOGNITION; CANCER IMMUNOTHERAPY; CLINICAL TRIAL; DENDRITIC CELL; HUMAN; IMMUNIZATION; MELANOMA; MELANOMA CELL; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PROTEIN EXPRESSION; SHORT SURVEY; T LYMPHOCYTE; TISSUE SPECIFICITY; ANIMAL; IMMUNOLOGY; IMMUNOTHERAPY; MALE; REVIEW; TESTIS;

ANIMALS; ANTIGENS, NEOPLASM; HUMANS; IMMUNOTHERAPY; MALE; MELANOMA; NEOPLASM PROTEINS; T-LYMPHOCYTES; TESTIS;

EID: 0032435604     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1998.tb02355.x     Document Type: Short Survey

References (3)

1. Blachcre, N.E., Li, Z., Chandawarker, R.Y, Suto, R., Jaikaria, N.S., Basu, S., Udono, H., and Srivastava, P.K. 1997. Heat shock protein peptide complexes, reconstituted in vitro, elic-it peptide specific cytotoxic T lymphocyte response and tumor immunity. J. Exp. Med. 186: 1315-1322.
2. Brichard, V., Van Pel, A., Wolfel, T., Wolfel, C., De Plaen, E., Lethe, B., Coulie, P., and Boon, T. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178: 489-495.
3. Brichard, V.G., Herman, J., Van Pel, A., Wildmann, C., Gaugler, B., Wolfel, T., Boon, T., and Lethe, B. 1996. A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes. Eur. J. Immunol. 26: 224-230.